Karie has noticed that in articles, some of the links in the footnotes that were migrated over, include mce in the link html. Is this an issue? Does this need to be removed?
One link from the new site includes mce between the a href:
Additional studies are ongoing to try to understand and improve upon the immune response generated in the RV144 trial. The
a _mce_href="http://www.vaccineenterprise.org/content/P5Partnership" href="http://www.vaccineenterprise.org/content/P5Partnership">P5 Partnership
(Pox-Protein Public-Private Partnership) has planned sequential future efficacy studies of RV144.
The same link on the old site does not include the mce between the a href:
Additional studies are ongoing to try to understand and improve upon the immune response generated in the RV144 trial. The
a href="http://www.vaccineenterprise.org/content/P5Partnership">P5 Partnership
(Pox-Protein Public-Private Partnership) has planned sequential future efficacy studies of RV144.
Karie has noticed that in articles, some of the links in the footnotes that were migrated over, include mce in the link html. Is this an issue? Does this need to be removed?
Example from new site http://lb88-ttgt.accessdomain.com/drupal/node/1479/edit
One link from the new site includes mce between the a href:
Additional studies are ongoing to try to understand and improve upon the immune response generated in the RV144 trial. The a _mce_href="http://www.vaccineenterprise.org/content/P5Partnership" href="http://www.vaccineenterprise.org/content/P5Partnership">P5 Partnership (Pox-Protein Public-Private Partnership) has planned sequential future efficacy studies of RV144.
Example from old site http://www.historyofvaccines.org/node/1479/edit
The same link on the old site does not include the mce between the a href:
Additional studies are ongoing to try to understand and improve upon the immune response generated in the RV144 trial. The a href="http://www.vaccineenterprise.org/content/P5Partnership">P5 Partnership (Pox-Protein Public-Private Partnership) has planned sequential future efficacy studies of RV144.